Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04616534
Title Testing the Addition of an Anti-cancer Drug, BAY 1895344 ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

peritoneum cancer

fallopian tube cancer

Advanced Solid Tumor

ovarian cancer

pancreatic adenocarcinoma

pancreatic cancer

Therapies

BAY1895344 + Gemcitabine

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.